Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ATBPF ANTIBE THERAPEUTICS INC

0.4480.0000.00%
Trading Session 09/29 09:42 ET
High
0.000
Open
0.419
Turnover
0.00
Low
0.000
Pre Close
0.448
Volume
65.00
Market Cap
23.34M
P/E(TTM)
Loss
52wk High
1.040
Shares
52.12M
P/E(Static)
Loss
52wk Low
0.419
Float Cap
23.34M
Bid/Ask %
0.00%
Historical High
5.000
Shs Float
52.12M
Volume Ratio
0.07
Historical Low
0.419
Dividend TTM
--
Div Yield TTM
--
P/B
0.61
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.000
Lot Size
1
Float Cap
23.34M
Bid/Ask %
0.00%
Historical High
5.000
Shs Float
52.12M
Volume Ratio
0.07
Historical Low
0.419
Dividend TTM
--
P/B
0.61
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.000
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the Antibe Therapeutics and Citagenix segments. The Antibe Therapeutics segment focuses on the development of pharmaceutical products. The Citagenix segment involves in the development and sale of regenerative medicines serving the dental and orthopedic market places. The company was founded by Andre Buret, John Wallace, and Giuseppe Cirino on May 5, 2009 and is headquartered in Toronto, Canada.
CEO: Mr. Daniel Legault
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...